Skip to content

Jointly Managing JIA Online: An Internet-based Psycho-educational Game for Children With JIA and Their Parents

Jointly Managing JIA Online: An Internet-based Psycho-educational Game for Children With Juvenile Idiopathic Arthritis (JIA) and Their Parents

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02610166
Enrollment
112
Registered
2015-11-20
Start date
2016-01-31
Completion date
2019-03-31
Last updated
2019-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Juvenile Idiopathic Arthritis

Brief summary

Arthritis in children is a long-term illness and it can make a child's life very difficult. In children 8-11 years old, the child and their family work together to deal with the problems that arthritis can cause. Learning to cope with and manage the problems that come with arthritis can stop it from getting worse. It is important to create programs that teach children and families how to cope with and manage arthritis. This study will develop and test an online game that helps children learn how to better manage their arthritis. The goal of these studies is to test: (1) how easy to use and acceptable the online game is; and (2) if children who play the game feel less pain, have fewer limitations, and a better quality of life compared to children who do not play the game.

Interventions

BEHAVIORALGame

In addition to standard medical care, children in the experimental group will receive the Match-3 game. The game will be designed for short individual gameplay sessions (as little as a few seconds), once to three times a day, over the course of 8 weeks, involving no more than 15 minutes per day in anticipated screen time. There is no way to lose the game. Through a structured series of daily interactions, the player will learn strategies and develop decision-making abilities that will assist with management of their own JIA. The Match 3 concept (similar to the game, Bejeweled) will require the player to successfully match the treatment strategy to the JIA symptom.

OTHERUsual Care

Children in usual care group receive standard medical care.

Sponsors

Provincial Health Services Authority British Columbia
CollaboratorOTHER
Alberta Children's Hospital
CollaboratorOTHER
Montreal Children's Hospital of the MUHC
CollaboratorOTHER
IWK Health Centre
CollaboratorOTHER
Children's Hospital of Eastern Ontario
CollaboratorOTHER
St. Justine's Hospital
CollaboratorOTHER
University of Toronto
CollaboratorOTHER
McGill University
CollaboratorOTHER
University of Florida
CollaboratorOTHER
Children's Hospital of Western Ontario
CollaboratorOTHER
University of Kansas Medical Center
CollaboratorOTHER
Memorial University of Newfoundland
CollaboratorOTHER
The Hospital for Sick Children
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
8 Years to 11 Years
Healthy volunteers
No

Inclusion criteria

1. Age ≥ 8 and ≤ 11 years of age 2. Diagnosed with JIA (minimum 3 months) using International League of Associations for Rheumatology classification criteria96 3. Active disease 4. Child and primary parent/caregiver are able to speak and read English or French 5. Participants are willing and able to complete online measures

Exclusion criteria

1. Cognitive impairments (as assessed by reviewing medical chart and consultation with the patient's rheumatologist) 2. Major co-morbid illnesses (e.g., medical \[inflammatory bowel disease, cancer, diabetes\] or psychiatric \[depression, anxiety\]) which may impact their ability to understand and use the game or complete outcome assessments (as determined by their rheumatologist). 3. Children currently participating in other Cognitive Behavioural Therapy (CBT) interventions 4. Usability testing participants

Design outcomes

Primary

MeasureTime frameDescription
Participant Accrual8 weeksThis will be centrally tracked by the clinical research project coordinator (CRPC).
Intervention Fidelity8 weeksAny issues or difficulties encountered during implementation of the intervention, control strategy, or outcome measures will be tracked throughout the study by the CRPC. For example, issues from a technical standpoint (for example, game not downloading properly, participant requiring assistance using the technology) or logistics standpoint.
Acceptability and Satisfaction with Intervention8 weeksImmediately post-trial children and parents in the intervention group will rate their acceptability of and satisfaction with the game and 10-15 English and 10-15 French children and one of their parents will take part in a brief qualitative interview.
Engagement with Intervention8 weeksAnalytics will be used to track patterns of website program usage (number of interactions \[clicks\]).
Dropout Rates8 weeksThis will be centrally tracked by the clinical research project coordinator (CRPC).

Secondary

MeasureTime frameDescription
Pain8 weeksMeasured using the Standardized Universal Pain Evaluations for Rheumatology providers for children and youth (SUPERKIDZ). It consists of 4 domains: pain intensity and location (5 items), fatigue (1 item), pain interference/evaluative dimension (10 items), and affective/emotional dimension (4 items) for children ≥ 8 years (and parent proxy report for children 4-8 years). This measure takes 3 - 5 minutes to complete.
Pain-related Activity Limitations8 weeksMeasured using the Child Activity Limitations Interview (CALI-21). This is a 21-item self-report scale divided into (i) active (e.g. gym, sports) and (ii) routine (e.g., schoolwork, reading) activity subscales.
Health-related Quality of Life8 weeksMeasured using the Arthritis Pediatric Quality of Life Inventory (PedsQL). The PedsQL Arthritis Module is a 22-item self-report scale with five subscales: pain and hurt, daily activities, treatment, worry, and communication.
Self Efficacy8 weeksMeasured using the Children's Arthritis Self-Efficacy Scale (CASE). The CASE is a disease specific 11-item self-report measure that is divided into three sub-scales: activity, symptom, and emotion. A 5-point Likert scale is used to rate responses to each item with 1 = not at all sure to 5 = very sure based on how confident the child is that they can manage disease effects.
JIA-specific Disease Knowledge8 weeksMeasured using the 24-item Medical Issues, Exercise, Pain and Social Support Questionnaire (MEPS). MEPS is made up of 4 sub scales (medical issues, exercise, pain, and social support). Items are rated on a 10-cm VAS with higher scores indicating greater disease knowledge.
Adherence8 weeksAdherence to medical treatment will be assessed using the 34-item Child Adherence Report Questionnaire (CARQ) that assesses adherence to prescribed medications, exercises, and wearing of splints over the past 3 months. The CARQ was developed specifically for children with JIA and consists of three sections: (1) responsibility for treatment, (2) child's ability to adhere to the three types of treatment, and (3) perceptions about helpfulness of therapies. Items in the last two sections are rated on 11-point numeric pain rating scale with higher scores indicating better adherence and perceived helpfulness of therapies.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026